00:00EMA stia lavorando molto closely con i suoi partner europei e internazionali
00:04per identificare le migliori soluzioni per adottare la composizione delle vaccini currently autorizzate
00:10COVID-19 in order to better match existing variants.
00:14As mentioned previously, we are looking at September as a potential time period
00:18for the approval of the first updated vaccines.
00:21Over the next few weeks, we anticipate to make significant progress on this front.
00:27We are developing both adapted monovalent and bivalent vaccines.
00:33Priority has been given to vaccines that incorporate Omicron BA1 variant
00:38in addition or in substitution of the original strain present in the current vaccines.
Commenti